German contract development and manufacturing organisation in Berlin, founded in 1994, which develops and makes biopharmaceuticals for clients worldwide. Provides cell line development with its own CHO and avian cell lines, process and analytical development, good manufacturing practice production of antibodies, glycoproteins and viral vaccines and vectors, and licenses its own technologies including the GlymaxX antibody glycoengineering platform and the AGE1.CR avian cell lines for vaccine and vector production.
No hay comentarios disponibles.
Deja tu valoración & comentario